Trial Outcomes & Findings for Effect of Head and Gaze Position on Soft Toric Contact Lens Performance (NCT NCT01579045)

NCT ID: NCT01579045

Last Updated: 2018-06-19

Results Overview

rotation from zero position also described as absolute value of the rotation.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

24 participants

Primary outcome timeframe

up to 60 minutes in recumbent position

Results posted on

2018-06-19

Participant Flow

Subjects were recruited and screened based on the inclusion/exclusion criteria.

Participant milestones

Participant milestones
Measure
All Subjects
All subjects who were enrolled.
Overall Study
STARTED
24
Overall Study
COMPLETED
24
Overall Study
NOT COMPLETED
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Effect of Head and Gaze Position on Soft Toric Contact Lens Performance

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Overall Subjects
n=24 Participants
All subjects who were enrolled, and completed the study.
Age, Continuous
43.2 years
STANDARD_DEVIATION 15.3 • n=5 Participants
Sex: Female, Male
Female
21 Participants
n=5 Participants
Sex: Female, Male
Male
3 Participants
n=5 Participants
Region of Enrollment
United Kingdom
24 participants
n=5 Participants

PRIMARY outcome

Timeframe: up to 60 minutes in recumbent position

Population: Subjects analyzed were those enrolled, randomized, and whom completed the study.

rotation from zero position also described as absolute value of the rotation.

Outcome measures

Outcome measures
Measure
Senofilcon A (AOfA)
n=24 Participants
As this was a non-dispensing study, the study lenses were worn only during the duration of the visit. Study lenses were marked with a non-toxic marker (e.g. surgical pen) prior to use to aid identification of the lens orientation markers. Each subject wore sequentially the 5 study lenses in a bilateral and random fashion at two different visits.
Filcon II 3 (Sauflon)
n=24 Participants
As this was a non-dispensing study, the study lenses were worn only during the duration of the visit. Study lenses were marked with a non-toxic marker (e.g. surgical pen) prior to use to aid identification of the lens orientation markers. Each subject wore sequentially the 5 study lenses in a bilateral and random fashion at two different visits.
Etafilcon A (1DAMfA)
n=24 Participants
As this was a non-dispensing study, the study lenses were worn only during the duration of the visit. Study lenses were marked with a non-toxic marker (e.g. surgical pen) prior to use to aid identification of the lens orientation markers. Each subject wore sequentially the 5 study lenses in a bilateral and random fashion at two different visits.
Filcon II 3 (C1DT)
n=24 Participants
As this was a non-dispensing study, the study lenses were worn only during the duration of the visit. Study lenses were marked with a non-toxic marker (e.g. surgical pen) prior to use to aid identification of the lens orientation markers. Each subject wore sequentially the 5 study lenses in a bilateral and random fashion at two different visits.
Nelfilcon A (FDT)
n=24 Participants
As this was a non-dispensing study, the study lenses were worn only during the duration of the visit. Study lenses were marked with a non-toxic marker (e.g. surgical pen) prior to use to aid identification of the lens orientation markers. Each subject wore sequentially the 5 study lenses in a bilateral and random fashion at two different visits.
Lens Orientation in Recumbent Position
15.8 degrees
Interval 11.23 to 20.44
35.2 degrees
Interval 30.62 to 39.79
19.4 degrees
Interval 14.6 to 24.22
29.1 degrees
Interval 24.23 to 33.95
21.7 degrees
Interval 16.86 to 26.48

SECONDARY outcome

Timeframe: up to 60 minutes in recumbent position

Population: Analysis is on those who were enrolled, randomized, and whom completed the study.

Visual Acuity measured in LogMAR units. High contrast visual acuity (VA) was measured in both eyes using a 3m LogMAR test chart at 2.5m testing distance (subsequently converted).

Outcome measures

Outcome measures
Measure
Senofilcon A (AOfA)
n=24 Participants
As this was a non-dispensing study, the study lenses were worn only during the duration of the visit. Study lenses were marked with a non-toxic marker (e.g. surgical pen) prior to use to aid identification of the lens orientation markers. Each subject wore sequentially the 5 study lenses in a bilateral and random fashion at two different visits.
Filcon II 3 (Sauflon)
n=24 Participants
As this was a non-dispensing study, the study lenses were worn only during the duration of the visit. Study lenses were marked with a non-toxic marker (e.g. surgical pen) prior to use to aid identification of the lens orientation markers. Each subject wore sequentially the 5 study lenses in a bilateral and random fashion at two different visits.
Etafilcon A (1DAMfA)
n=24 Participants
As this was a non-dispensing study, the study lenses were worn only during the duration of the visit. Study lenses were marked with a non-toxic marker (e.g. surgical pen) prior to use to aid identification of the lens orientation markers. Each subject wore sequentially the 5 study lenses in a bilateral and random fashion at two different visits.
Filcon II 3 (C1DT)
n=24 Participants
As this was a non-dispensing study, the study lenses were worn only during the duration of the visit. Study lenses were marked with a non-toxic marker (e.g. surgical pen) prior to use to aid identification of the lens orientation markers. Each subject wore sequentially the 5 study lenses in a bilateral and random fashion at two different visits.
Nelfilcon A (FDT)
n=24 Participants
As this was a non-dispensing study, the study lenses were worn only during the duration of the visit. Study lenses were marked with a non-toxic marker (e.g. surgical pen) prior to use to aid identification of the lens orientation markers. Each subject wore sequentially the 5 study lenses in a bilateral and random fashion at two different visits.
Monocular Visual Acuity in Recumbent Position
-0.008 units on a scale (LogMAR)
Interval -0.044 to 0.029
0.041 units on a scale (LogMAR)
Interval 0.005 to 0.077
0.024 units on a scale (LogMAR)
Interval -0.008 to 0.055
0.081 units on a scale (LogMAR)
Interval 0.049 to 0.114
-0.013 units on a scale (LogMAR)
Interval -0.045 to 0.019

Adverse Events

Senofilcon A (AOfA)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Filcon II 3 (Sauflon)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Etafilcon A (1DAMfA)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Filcon II 3 (C1DT)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Nelfilcon A (FDT)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Katherine Osborn Lorenz, OD MS

Vistakon/Johnson & Johnson Vision Care

Phone: 904-443-3123

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place

Restriction type: LTE60